We are live on ! Find out more
KF

Krilogy Financial Portfolio holdings

AUM $3.11B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+20.67%
3 Year Est. Return
+53.36%
5 Year Est. Return
+52.45%
10 Year Est. Return
+165.81%
AUM
$108M
AUM Growth
-$102M
Cap. Flow
-$109M
Cap. Flow %
-101.1%
Top 10 Hldgs %
55.9%
Holding
666
New
51
Increased
112
Reduced
77
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 4.63%
2 Healthcare 3.05%
3 Financials 2.79%
4 Communication Services 2.51%
5 Energy 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHC icon
376
Bausch Health
BHC
$1.65B
$2K ﹤0.01%
20
-180
-90% -$20.2K
CPA icon
377
Copa Holdings
CPA
$5.56B
$2K ﹤0.01%
32
EXAS
378
DELISTED
Exact Sciences
EXAS
$2K ﹤0.01%
+250
New +$2.33K
HPQ icon
379
HP
HPQ
$23.5B
$2K ﹤0.01%
181
-218
-55% -$2.79K
MNKD icon
380
MannKind Corp
MNKD
$1.28B
$2K ﹤0.01%
212
+12
+6% +$148
QSR icon
381
Restaurant Brands International
QSR
$25.1B
$2K ﹤0.01%
65
SDS icon
382
ProShares UltraShort S&P500
SDS
$424M
$2K ﹤0.01%
1
TEL icon
383
TE Connectivity
TEL
$58.8B
$2K ﹤0.01%
+32
New +$2.06K
TOVX icon
384
Theriva Biologics
TOVX
$10.2M
0
UNIT
385
Uniti Group
UNIT
$2.63B
$2K ﹤0.01%
104
WYNN icon
386
Wynn Resorts
WYNN
$10.1B
$2K ﹤0.01%
25
XT icon
387
iShares Future Exponential Technologies ETF
XT
$3.77B
$2K ﹤0.01%
+96
New +$2.38K
CHK
388
DELISTED
Chesapeake Energy Corporation
CHK
$2K ﹤0.01%
3
+2
+200% +$2.49K
STML
389
DELISTED
Stemline Therapeutics, Inc.
STML
$2K ﹤0.01%
300
FCSC
390
DELISTED
Fibrocell Science Inc.
FCSC
$2K ﹤0.01%
33
ARRY
391
DELISTED
Array Biopharma Inc
ARRY
$2K ﹤0.01%
500
WGL
392
DELISTED
Wgl Holdings
WGL
$2K ﹤0.01%
27
ANTH
393
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$2K ﹤0.01%
+63
New +$2.78K
POT
394
DELISTED
Potash Corp Of Saskatchewan
POT
$2K ﹤0.01%
100
KEM
395
DELISTED
KEMET Corporation
KEM
$2K ﹤0.01%
999
OIL
396
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
$2K ﹤0.01%
316
BB icon
397
BlackBerry
BB
$5.01B
$1K ﹤0.01%
135
-200
-60% -$1.54K
BLRX
398
BioLineRX
BLRX
$12.3M
$1K ﹤0.01%
2
BMO icon
399
Bank of Montreal
BMO
$125B
$1K ﹤0.01%
12
-688
-98% -$39.6K
CDE icon
400
Coeur Mining
CDE
$15.6B
$1K ﹤0.01%
500

Similar funds

Krilogy Financial's Q4 2015 Portfolio in Review

As of Q4 2015, Krilogy Financial held 666 positions worth $108M, down 49% from $210M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Krilogy Financial withdrew a net $109M in Q4 2015, closing 227 positions and reducing 77 holdings. Its most notable exit was Schwab US Large-Cap Growth ETF, an estimated $21.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 1.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Krilogy Financial opened a new position in Alphabet (Google) Class A worth $303K.

  • Krilogy Financial's largest Q4 2015 buy was Alphabet (Google) Class A: 7,800 shares worth $303K.
  • Krilogy Financial added most to Apple in Q4 2015, an estimated $3.11M increase.
  • Krilogy Financial's biggest Q4 2015 reduction was Amazon, cutting an estimated $8.28M.
  • Krilogy Financial fully exited Schwab US Large-Cap Growth ETF in Q4 2015, selling an estimated $21.5M.
  • Krilogy Financial's ten largest holdings make up 56% of its $108M portfolio in Q4 2015.
  • Krilogy Financial opened 51 new positions and closed 227 in Q4 2015.
  • Krilogy Financial's portfolio value fell 49% quarter-over-quarter to $108M.

Based on Krilogy Financial's 13F filing for Q4 2015, filed 29 Feb 2016.